Annual Short Term Debt
$227.62 M
+$122.98 M+117.53%
31 December 2023
Summary:
Amneal Pharmaceuticals annual short term debt is currently $227.62 million, with the most recent change of +$122.98 million (+117.53%) on 31 December 2023. During the last 3 years, it has risen by +$170.15 million (+296.05%). AMRX annual short term debt is now at all-time high.AMRX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$381.02 M
-$70.63 M-15.64%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly short term debt is currently $381.02 million, with the most recent change of -$70.63 million (-15.64%) on 30 September 2024. Over the past year, it has increased by +$258.51 million (+211.01%). AMRX quarterly short term debt is now -15.64% below its all-time high of $451.65 million, reached on 30 June 2024.AMRX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +117.5% | +211.0% |
| 3 y3 years | +296.1% | +738.4% |
| 5 y5 years | +948.2% | +895.1% |
AMRX Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +394.4% | -15.6% | +738.4% |
| 5 y | 5 years | at high | +948.2% | -15.6% | +931.1% |
| alltime | all time | at high | +948.2% | -15.6% | +1654.6% |
Amneal Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $381.02 M(-15.6%) |
| June 2024 | - | $451.65 M(+97.5%) |
| Mar 2024 | - | $228.66 M(+0.5%) |
| Dec 2023 | $227.62 M(+117.5%) | $227.62 M(+85.8%) |
| Sept 2023 | - | $122.51 M(-26.4%) |
| June 2023 | - | $166.48 M(+14.6%) |
| Mar 2023 | - | $145.22 M(+38.8%) |
| Dec 2022 | $104.64 M(+127.3%) | $104.64 M(-1.8%) |
| Sept 2022 | - | $106.57 M(-18.7%) |
| June 2022 | - | $131.13 M(+182.9%) |
| Mar 2022 | - | $46.35 M(+0.7%) |
| Dec 2021 | $46.04 M | $46.04 M(+1.3%) |
| Sept 2021 | - | $45.45 M(+4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $43.70 M(+3.2%) |
| Mar 2021 | - | $42.36 M(-26.3%) |
| Dec 2020 | $57.47 M(+55.5%) | $57.47 M(+24.4%) |
| Sept 2020 | - | $46.20 M(-1.9%) |
| June 2020 | - | $47.08 M(-86.4%) |
| Mar 2020 | - | $346.94 M(+838.9%) |
| Dec 2019 | $36.95 M(+70.2%) | $36.95 M(-3.5%) |
| Sept 2019 | - | $38.29 M(+0.6%) |
| June 2019 | - | $38.05 M(+0.5%) |
| Mar 2019 | - | $37.85 M(+74.3%) |
| Dec 2018 | $21.71 M(-75.7%) | $21.71 M(-89.1%) |
| Sept 2018 | - | $199.82 M(+101.4%) |
| June 2018 | - | $99.23 M(+10.9%) |
| Dec 2017 | $89.48 M | $89.48 M |
FAQ
- What is Amneal Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual short term debt year-on-year change?
- What is Amneal Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly short term debt year-on-year change?
What is Amneal Pharmaceuticals annual short term debt?
The current annual short term debt of AMRX is $227.62 M
What is the all time high annual short term debt for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual short term debt is $227.62 M
What is Amneal Pharmaceuticals annual short term debt year-on-year change?
Over the past year, AMRX annual short term debt has changed by +$122.98 M (+117.53%)
What is Amneal Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of AMRX is $381.02 M
What is the all time high quarterly short term debt for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly short term debt is $451.65 M
What is Amneal Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, AMRX quarterly short term debt has changed by +$258.51 M (+211.01%)